TGA Approval

TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack (370977)

ARTG ID

370977

ARTG Name

TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack

Sponsor

Merck Healthcare Pty Ltd

ARTG Date

January 17, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Merck Healthcare Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/2695cb061466fffc36481ffdc9ee9983.pdf

https://medical-cdn.nocode.com/drug_tga/5b6470f76c390a57f2ca91ace15f396a.pdf

Ingredient Name

tepotinib hydrochloride monohydrate

Empowering clinical research with data-driven insights and AI-powered tools.

TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack (370977) - TGA 批准文号 | MedPath